MLPLX | OSPAX | MLPLX / OSPAX | |
Total Expense Ratio | 8.06 | 2.76 | 292% |
Annual Report Gross Expense Ratio | 8.06 | 2.76 | 292% |
Fund Existence | 13 years | 12 years | - |
Gain YTD | 4.039 | 4.391 | 92% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 1000 | 1000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 305M | 1.1B | 28% |
Annual Yield % from dividends | 5.32 | 4.94 | 108% |
Returns for 1 year | 27.34 | 26.09 | 105% |
Returns for 3 years | 112.48 | 94.54 | 119% |
Returns for 5 years | 344.88 | 245.25 | 141% |
Returns for 10 years | 29.98 | 53.71 | 56% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SHPAX | 19.06 | -0.09 | -0.47% |
Saratoga Health & Biotechnology A | |||
DEMAX | 24.36 | -0.29 | -1.18% |
Macquarie Emerging Markets A | |||
IOAPX | 27.86 | -0.35 | -1.24% |
Invesco Main Street All Cap R6 | |||
PICEX | 7.13 | -0.09 | -1.25% |
Virtus SGA Emerging Markets Equity C | |||
AIGIX | 21.39 | -0.30 | -1.38% |
Alger International Opportunities I |